Herein, our aim was to study the impact of a subcutaneous pellet administration of the MR-antagonist eplerenone, on the systemic and epididymal White adipose tissue (eWAT) RAAS components and inflammation in an animal model of obesity. Here, NR3C2 is linked to obesity disorder.